HPV Assay Adjunctive Use With Pap Test Needs U.S. Patient Data - FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Foreign clinical data supporting human papilloma virus (HPV) testing as an adjunct to Pap smear in screening for cervical cancer need to be confirmed in U.S. studies, FDA's Microbiology Devices Panel recommended at its recent meeting in Gaithersburg, Maryland.